https://www.sec.gov/ix?doc=/Archives/edgar/data/0001728328/000121390026024752/ea0279869-8k_inmed.htm
On March 4, InMed Pharmaceuticals Confirmed And Approved The Decision To Wind Down BayMedica's Commercial Operations; BayMedica To Complete Wind Down Before Fiscal Year Ending June 30, 2026
Login to comment